ArticleJournal of human immunity2026
Human inborn errors of the phagocyte respiratory burst: Chronic granulomatous disease and beyond.
Article in Journal of human immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The phagocyte respiratory burst is an effector mechanism of immunity by which granulocytes, monocytes, and other myeloid cells generate reactive oxygen species (ROS). Inborn errors of core phagocyte NADPH oxidase components (gp91phox, p22phox, p47phox, and p67phox) underlie most cases of chronic granulomatous disease, characterized by severe, recurrent bacterial and fungal infections. An expanding spectrum of inborn errors of immunity (IEIs) has been identified that affect molecules that trigger (IFN-γ, TNF, and their signaling pathways) or control NADPH oxidase assembly and activation (EROS, p40phox, PKCδ, RAC2, and DOCK2), thereby impairing ROS production. Studies of these genetic disorders, which include infection, autoinflammation, and autoimmunity, have identified crucial pathways governing the induction, regulation, assembly, priming, activation, and function of the phagocyte NADPH oxidase complex. We review here the diverse IEIs affecting phagocyte ROS production, highlighting disorders in which ROS generation is absent, reduced, or subset-specific, and the corresponding cellular, immunological, and clinical phenotypes.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.